IDL Biotech AB (XSAT:IDL) Net Issuance of Preferred Stock : kr0.00 Mil (TTM As of Jun. 2021)

View and export this data going back to 2004. Start your Free Trial

What is IDL Biotech AB Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

IDL Biotech AB's net issuance of preferred for the three months ended in Jun. 2021 was kr0.00 Mil. The number is 0, which means that IDL Biotech AB has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

IDL Biotech AB's net issuance of preferred for the trailing twelve months (TTM) ended in Jun. 2021 was kr0.00 Mil.

IDL Biotech AB Net Issuance of Preferred Stock Historical Data

The historical data trend for IDL Biotech AB's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDL Biotech AB Net Issuance of Preferred Stock Chart

IDL Biotech AB Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

IDL Biotech AB Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

IDL Biotech AB Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

IDL Biotech AB Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

IDL Biotech AB (XSAT:IDL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Biotech AB (XSAT:IDL) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Karlsbodavagen 39, Stockholm, SWE

Website

http://www.idl.se

IDL Biotech AB develops, produces and markets In Vitro Diagnostic tests for the health care sector. It offers in vitro diagnostic tests within the clinical areas of oncology and bacteriology. The company's trademark products includes TUBEX, TPS, UBC, MonoTotal and TPAcyk.

IDL Biotech AB (XSAT:IDL) Headlines

No Headlines